Literature DB >> 1443878

A specific and potent pressor effect of hypoxia in patients with sleep apnea.

J A Hedner1, I Wilcox, L Laks, R R Grunstein, C E Sullivan.   

Abstract

A hypoxic ramp test (to 75% arterial oxygen saturation) during the awake state was performed in 17 patients with obstructive sleep apnea (OSA). Blood pressure was monitored with an indwelling arterial line (radial artery), and the ventilatory response to eucapnic hypoxia was determined. Eight of the patients were normotensive. The remaining nine hypertensive patients were studied after a 3-wk washout of antihypertensive medication. Compared with a nonmatched group of normotensive nonsnoring control subjects in whom hypoxemia did not affect blood pressure, all OSA patients showed various degrees of pressor responses during hypoxia. The pressor response was of similar magnitude in normotensive and hypertensive patients with OSA. There was a significant relationship between the ventilatory and the pressor responses to hypoxia (p = 0.03) that was similar in both normotensive and hypertensive patients. Although disease severity expressed as apnea index (number of apneas per hour of sleep) or minimum arterial oxygen saturation reached during the overnight recording correlated with the magnitude of the pressor response (p = 0.03 and 0.045, respectively), the ventilatory response to hypoxia was unrelated to disease severity. Hypoxemia induced a similar increase in heart rate in controls and in normotensive patients, but an attenuated heart rate response was seen at the nadir of oxygen saturation in hypertensive subjects (p < 0.05). These data demonstrate that patients with obstructive sleep apneas have a pressor response to hypoxia. This response is likely to be involved in the blood pressure swings seen during apnea in patients with OSA.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443878     DOI: 10.1164/ajrccm/146.5_Pt_1.1240

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  27 in total

Review 1.  "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease.

Authors:  I Wilcox; S G McNamara; F L Collins; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  Sleep apnoea and autonomic function.

Authors:  C W Zwillich
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 3.  Sleep apnoea and snoring: potential links with vascular disease.

Authors:  C E Sullivan; S G McNamara
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 4.  Treatment options for sleep apnoea.

Authors:  R R Grunstein; J Hedner; L Grote
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  Sympatho-adrenal activation by chronic intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar; Ying-Jie Peng
Journal:  J Appl Physiol (1985)       Date:  2012-06-21

6.  DNA methylation in the central and efferent limbs of the chemoreflex requires carotid body neural activity.

Authors:  Jayasri Nanduri; Ying-Jie Peng; Ning Wang; Shakil A Khan; Gregg L Semenza; Nanduri R Prabhakar
Journal:  J Physiol       Date:  2018-01-04       Impact factor: 5.182

Review 7.  Carotid body chemoreflex: a driver of autonomic abnormalities in sleep apnoea.

Authors:  Nanduri R Prabhakar
Journal:  Exp Physiol       Date:  2016-08-01       Impact factor: 2.969

Review 8.  Hypoxia-inducible factors and obstructive sleep apnea.

Authors:  Nanduri R Prabhakar; Ying-Jie Peng; Jayasri Nanduri
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

9.  The effect of repeated acute hypoxaemia on fetal cardiovascular development in the sheep.

Authors:  C Steyn; M A Hanson
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

10.  Pulmonary hemodynamics in obstructive sleep apnea: frequency and causes of pulmonary hypertension.

Authors:  M Hetzel; M Kochs; N Marx; H Woehrle; I Mobarak; V Hombach; J Hetzel
Journal:  Lung       Date:  2003       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.